CDKN2A and fibrosarcoma: Mice that are void of Arf (but retain wild-type INK4a) begin developing tumors (fibrosarcomas and lymphomas) as early as 8 weeks of age and, after one year, 80% of Arf−/− mice succumb to spontaneous tumor development [10].